Which of the following is given to treat thrombocytopenia secondary to anti-cancer therapy and is known to stimulate progenitor megakaryocytes
Ans. is 'b' i.e., Oprelvekin
Filgrastim
Oprelvekin
Erythropoietin
Anagrelide